Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.

Threat actors are abusing Pastebin comments to distribute a new ClickFix-style attack that tricks cryptocurrency users into ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

In 2024, Demis Hassabis won a Nobel Prize in chemistry for his work in predicting protein structures through his company, Isomorphic Labs. The lab, which broke off from Google's DeepMind in 2021, ...

To be human is, fundamentally, to be a forecaster. Occasionally a pretty good one. Trying to see the future, whether through the lens of past experience or the logic of cause and effect, has helped us ...

Fox News calls Arizona Class 1 Seat for Ruben Gallego. Nov 9 • 6:44 AM ET Fox News calls Nevada Class 1 Seat for Jacky Rosen. Nov 7 • 5:54 PM ET Fox News calls Pennsylvania Class 1 Seat for Dave ...